Streetbeat News

Products Services

NIO

TSLA

Chinese electric vehicle maker Nio Inc has obtained an internet access license for its inaugural smartphone, marking a significant step towards smartphone production. The smartphone, which supports 5G and dual-SIM card usage, is expected to be released in the third quarter. Meanwhile, Tesla's plans for an 'alternative phone' remain unclear.

Portfolio Pulse from Ramakrishnan M

August 04, 2023 | 2:47 pm

FSR

TSLA

Fisker Inc. has unveiled its latest electric vehicle, the Ronin, a four-door convertible aimed at competing with Tesla's Roadster. The vehicle boasts impressive specs, including a 0 to 60 mph acceleration in about 2 seconds and around 1,000 horsepower. However, the technology behind the Ronin is not fully developed yet, with the launch planned for the end of 2025. Fisker is currently facing financial challenges with its Ocean program, losing $120 million a quarter.

Portfolio Pulse from Benzinga Neuro

August 04, 2023 | 2:46 pm

CAT

PLTR

Palantir Technologies Inc. (PLTR) and WesTrac Pty Ltd, a Caterpillar dealer, have announced a multi-year expansion of their partnership to deploy Palantir's Foundry across WesTrac's core operations. The expanded partnership will focus on WesTrac's Component Rebuild Centres and Inventory Management teams.

Portfolio Pulse from Charles Gross

August 04, 2023 | 2:46 pm

HOOD

IGGHY

A new app called 'Bad Trader', owned by IG Group Holdings ADR (OTC:IGGHY), is targeting young investors with a focus on community, speculation, and calculated risk-taking. The app, which is directly competing with Robinhood Markets Inc (NASDAQ:HOOD) and eToro, offers live streams and chat rooms to help users understand when to take calculated risks. The app is available on both iOS and Android platforms.

Portfolio Pulse from AJ Fabino

August 04, 2023 | 2:44 pm

ONCT

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) has received a Study May Proceed letter from the FDA for a Phase 1/2 dose escalation study of ONCT-534, a novel dual-action androgen receptor inhibitor, in patients with metastatic castration-resistant prostate cancer. The company expects to report preliminary data in the first half of 2024.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:41 pm

TNDM

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has announced a limited time offer for its Tandem Choice technology access program. This program allows new and renewing t:slim X2 Insulin Pump customers in the US to purchase the Tandem Mobi System for $199. The Tandem Mobi, recently cleared by the FDA, is expected to launch later this year with general availability in early 2024.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:39 pm

LIAN

LianBio (NASDAQ:LIAN) has announced the first patient has been dosed in its Phase 1 clinical trial of BBP-398, an investigational SHP2 inhibitor, in combination with AstraZeneca's osimertinib, for the treatment of patients with non-small cell lung cancer (NSCLC) with EGFR mutations. The trial is designed to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of BBP-398 in combination with osimertinib. BBP-398 is being developed for difficult-to-treat cancers and was founded through a collaboration between BridgeBio and The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:39 pm

AAPL

Apple has announced that its installed base of active devices has reached an all-time high in every geographic segment.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:36 pm

CMPS

HTGC

COMPASS Pathways (NASDAQ:CMPS) reported Q2 2023 financial results, with cash and cash equivalents totaling $148.2 million, up from $143.2 million in Dec. 2022. The company's Q2 financing included $26.9 million through an ATM facility and $28.8 million through a term loan agreement with Hercules Capital (NYSE:HTGC). The company reported a net loss of $28.3 million for Q2 and $52.5 million for H1 2023. CEO Kabir Nath highlighted steady progress across the business, including ongoing Phase 3 COMP360 psilocybin trials in Treatment-Resistant Depression (TRD).

Portfolio Pulse from Lara Goldstein

August 04, 2023 | 2:24 pm

FSR

Fisker CEO announced on Fox Business that the company expects to produce 300 Fisker Ocean EVs per day later this year.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 2:24 pm